Cross-sectional studies, 110

D

Dementia of the Alzheimer type, 237–242

primary study, 237–238

secondary studies, 238–240

Dementia pugilistica (DP), 243–246

secondary studies, 244–245

summary and conclusions, 245–246

Diabetes insipidus, 231.

See also Endocrine disorders

Diffuse traumatic brain injury, 26–27, 41

Diffusion-tensor imaging (DTI), 21–22

Dilantin Prophylaxis of Post-Traumatic Seizures, 134–136

Dizziness, 218.

See also Postconcussion symptoms

Dose-response relationships, in inferring causality, 107–108

Drug and alcohol abuse disorders, 291

secondary studies, 291

summary and conclusions, 293

Dynamic loading, 27–28

E

E.A. Walker's studies of head-injured veterans

from World War I, 119, 143

from World War II, 119–121, 144–145

Endocrine disorders, 227–236

diabetes insipidus, 231

growth hormone insufficiency, 231–232

hypopituitarism, 231

primary studies, 227–230

secondary studies, 230–231

summary and conclusions, 231–232

Epidemiologic studies, 105

Epidemiology of adult traumatic brain injury, 59–102

brain injury severity, 63–64

gross severity of traumatic brain injury, 59–60

incidence of traumatic brain injury, 61–63

outcome scores and predictors, 60

recurrent traumatic brain injury, 67–68

risk factors for traumatic brain injury, 64–67

scales and scoring systems used to describe traumatic brain injury, 59

summary, 69

traumatic brain injury and short-term outcomes, 68–69

Front Matter (R1-R14)

SUMMARY (1-12)

1 INTRODUCTION (13-18)

2 BIOLOGY OF TRAUMATIC BRAIN INJURY (19-58)

3 EPIDEMIOLOGY OF ADULT TRAUMATIC BRAIN INJURY (59-102)

4 CONSIDERATIONS IN IDENTIFYING AND EVALUATING THE LITERATURE (103-116)

5 MAJOR COHORT STUDIES (117-172)

6 NEUROCOGNITIVE OUTCOMES (173-196)

7 NEUROLOGIC OUTCOMES (197-264)

8 PSYCHIATRIC OUTCOMES (265-300)

9 SOCIAL FUNCTIONING (301-332)

10 OTHER HEALTH OUTCOMES (333-366)

11 CONCLUSIONS AND RECOMMENDATIONS (367-372)

INDEX (373-382)